Bepotastine Besilate from Alfa Chemistry

Description

Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively. The ophthalmic solution is FDA-approved since Sept 8, 2009.